Table 1. Subjects in CDU TMA.
N (%) | |
---|---|
Total | 204 |
Ethnicity | |
African American | 50 (24.5) |
Hispanic | 28 (13.7) |
Asian | 126 (61.8) |
Age (yr) | |
<50 | 90 (44.1) |
≥50 | 114 (55.9) |
ERα/PR status | |
Positive | 130 (63.7) |
Negative | 74 (36.3) |
HER2 status | |
Positive (IHC 3+/FISH amplified) | 52 (25.5) |
Negative | 152 (74.5) |
Subtype (by receptors) | |
ERα/PR+/HER2- | 104 (51.0) |
HER2+ | 52 (25.5) |
TNBC | 48 (23.5) |
Tumor size | |
≤ 2cm | 45 (22.1) |
2cm – 5cm | 115 (56.4) |
> 5cm | 32 (15.7) |
Unknown | 12 (5.9) |
Node | |
Negative | 68 (33.3) |
Positive | 127 (62.3) |
Unknown | 9 (4.4) |
Stage | |
0-II | 134 (65.7) |
III-IV | 66 (32.4) |
unknown | 4 (2.0) |
ERβ (nuclear) | |
Positive | 121 (59.3) |
Negative | 83 (40.7) |
IGF2 | |
IGF2-positive | 41 (19.7) |
IGF2-negative | 159 (76.4) |
missing | 8 (3.8) |